Complement inhibition in severe COVID-19 - Blocking C5a seems to be key: Author''s reply.
Complement inhibition in severe COVID-19 - Blocking C5a seems to be key: Author''s reply.. Annane, D; Grimaldi-Bensouda, L; Fremeaux-Bacchic, V. EClinicalMedicine. 2021; 35: p.100866-100866. doi:10.1016/j.eclinm.2021.100866
Echappement aux anti-infectieux et pharmacoépidémiologie